Clinical Trials Directory

Trials / Completed

CompletedNCT04281121

Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver

the Effect of Omega 3 Fatty Acids Supplements on Antioxidant Capacity in Egyptian Children With Non Alcoholic Fatty Liver Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
6 Years – 16 Years
Healthy volunteers
Not accepted

Summary

this is a prospective, interventional, open-label, randomized study on the efficacy of omega 3 fatty acids supplementation in Egyptian children with non-alcoholic fatty liver disease who had been selected from nutrition and outpatient clinic at Pediatric hospital, Ain Shams University

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTomega 3 fatty acids: Life style modification, diet regimen and Omega-3 fatty acids supplementation: The dose of omega-3 fatty acids depended on the weight of patients according to World Health Organization recommendations 400 milligrams per 10 kilograms of body weight and had been given into two doses per day, before morning and evening meals

Timeline

Start date
2019-03-01
Primary completion
2020-01-25
Completion
2020-02-19
First posted
2020-02-24
Last updated
2020-02-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04281121. Inclusion in this directory is not an endorsement.